Loss of heterozygosity on chromosome 22q and 17p correlates with aggressiveness of meningiomas

Journal of Neuro-Oncology

Volumn 40, Issue 2, 1998, Pages 101-106

  Kim, Jong Hyun ^a   Lee, Seung Hoon ^b   Rhee, Chang Hun ^b   Park, Sang Yoon ^b   Lee, Je Ho ^c  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Korea Cancer Center Hospital   (South Korea)

^c Sungkyunkwan University   (South Korea)

Author keywords

Aggressiveness; Chromosome 17p; Chromosome 22q; Invasive meningioma; Loss of heterozygosity (LOH); Malignant meningioma

Indexed keywords

DNA MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CHROMOSOME 17P; CHROMOSOME 22Q; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE INACTIVATION; GENE LOCUS; HEMANGIOPERICYTOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; MALE; MALIGNANT MENINGIOMA; MALIGNANT TRANSFORMATION; NEUROFIBROMATOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ADULT; AGED; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 22; DNA, NEOPLASM; FEMALE; HETEROZYGOTE; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 0032437640     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006110812240     Document Type: Article

References (24)

1. Nakasu S, Hirano A, Llena JF, Shimura T, Handa J: Interface between the meningioma and the brain. Surg Neurol 32: 206-212, 1989
2. Russell DS, Rubinstein LJ: Pathology of tumours of the nervous system. (5th ed.) Edward Arnold, London, Melbourne, Auckland 1989, pp 449-505
3. Weller RO: Color atlas of neuropathology. Oxford University Press, New York 1984, pp 84-85
4. Zankle H, Zang KD: Correlation between clinical and cytogenetical data in 180 human meningionias. Cancer Genet Cytogenet 1: 351-356, 1980
5. Zang KD: Cytological and cytogenetical studies on human meningioma. Cancer Genet Cytogenet 6: 249-274, 1982
6. Dumanski JP, Carlbom E, Collins VP, Nordenskjold M: Deletion mapping of a locus on human chromosome 22 involved in the oncogenesis of meningioma. Proc Natl Acad Sci USA 84: 9275-9279, 1987
7. Dumanski JP, Rouleau GA, Nordenskjold M, Collins VP: Molecular genetic analysis of chromosome 22 in 81 cases of meningioma. Cancer Res 50: 5863-5867, 1990
8. Meese E, Blin N, Zang KD: Loss of heterozygosity and origin of meningioma. Hum Genet 77: 349-351, 1987
9. Seizinger BR, Monte SDL, Atkins L, Gusella JF, Martuza RL: Molecular genetic approach to human meningioma: loss of genes on chromosome 22. Proc Natl Acad Sci USA 84: 5419-5423, 1987
10. Seizinger BR, Rouleau G, Ozelius LJ, Lane AH, George-Hyslop P, Huson S, Gusella JF, Martuza RL: Common pathogenetic mechanism for three tumor types in bilateral acoustic neurofibromatosis. Science 236: 317-319, 1987
11. Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM: p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res 52: 674-679, 1992
12. James WK: Clonal genomic alterations in glioma malignancy stages. Cancer Res 48: 5546-5551, 1988
13. Raffel C, Gilles FE, Weinberg KI: Reduction to homozygosity and gene amplification in central nervous system primitive neuroectodermal tumors of childhood. Cancer Res 50: 587-591, 1990
14. Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallic BL, Murphree AL, Strong LC, White R: Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305: 779-784, 1983
15. Feinberg A, Vogelstein B: A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132: 6, 1983
16. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hosteller R, Cleary K, Binger SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Weston A, Modari R, Harris CC, Vogelstein B: Mutations in the p53 gene occur in diverse human tumour types. Nature 342: 705-708, 1989
17. Al Saadi A, Latimer F, Madercic M, Robbins T: Cytogenetic studies of human brain tumors and their clinical significance. II. Meningioma. Cancer Genet Cytogenet 26: 127-141, 1982
18. Sanson M, Richard S, Delattre O, Poliwka M, Mikol J, Philippon J, Thomas G: Allelic loss on chromosome 22 correlates with histopathological predictors of recurrence of meningiomas. Int J Cancer 50: 392-394, 1992
19. Christiansen H, Lamport F: Tumor karyotype discriminates between good and bad prognostic outcome in neuroblastoma. Brit J Cancer 57: 121-126, 1988
20. Fong CT, Dracopoli NC, White PS, Merrill PT, Griffith RC, Housman DE, Brodeur GM: Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification. Proc Natl Acad Sci USA 68: 3753-3757, 1989
21. Fujimoto M, Fults DW, Thomas GA, Nakamura Y, Heilbrun MP, White R, Story JL, Naylor SL, Kagan-Hallet KS, Sheridan PJ: Loss of heterozygosity chromosome 10 in human glioblastoma multiforme. Genomics 4: 210-214, 1989
22. Cogen PH, Daneshvar L, Metzger AK, Edwards MSB: Deletion mapping of the medulloblastoma locus on chromosome 17p. Genomics 8: 279-285, 1990
23. Mashiyama S, Murakami Y, Yoshimoto T, Sekiya T, Hayashi K: Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products, Oncogene 6: 1313-1318, 1991
24. Pykett MJ, Landers J, George DL: Expression patterns of the p53 tumor suppressor gene and the mdm proto-oncogene in human meningiomas. J Neurooncol 32(1): 39-44, 1997